(HealthDay News) — The number of US adults with severe obesity increased from 2013 to 2023, according to a research letter published online Feb. 13 in the Journal of the American Medical Association.

Obesity affects over a third of Missouri's adults and children, with rural areas hit hardest. It's a complex issue linked to mental health and accessibility, not just personal choice.

A new generation of anti-obesity drugs aims for greater effectiveness, fewer side effects, and more convenience.

U.S. investors and large pharmaceutical companies are increasingly doing deals in China as the country’s biopharma sector ...

From school meals to food labelling standards, contributors to our mini-series on Cayman's obesity crisis highlight a range ...

Childhood obesity has been on the rise in the United States for over a decade, and, according to the American Heart Association (AHA), approximately one in three children and teenagers lives with ...

Eli Lilly’s profit doubled in the fourth quarter, propelled by its hot-selling diabetes and obesity treatments, and the drugmaker came out with a mostly better-than-expected 2025 forecast.

Novo Nordisk, the Danish pharmaceutical giant, has announced slower growth projections for the upcoming year, following a remarkable doubling of sales for its obesity drug Wegovy in the final quarter ...

LONDON/SAN FRANCISCO, Feb 4 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab is under pressure from investors for more information about its next-generation obesity drug candidate CagriSema amid ...